FDA Orders Two Companies to Stop Making Unapproved Nitroglycerin

摘要

The FDA has ordered two generic-drug makers to stop making and selling unapproved nitroglycerin tablets, which are used to relieve chest pain or stop a heart attack.rnGlenmark Generics' and Konec's 0.3-, 0.4-and 0.6-mg nitroglycerin tablets have not been proven safe and effective, and the FDA has not reviewed the quality and labeling of the products, according to warning letters released last week.